Healthcare >> CEO Interviews >> February 19, 2001
For three years prior to his appointment as President and Chief
Executive Officer, Dr. Gerald J. Yakatan served as Vice President for
drug development at AVANIR Pharmaceuticals. He was appointed to the
AVANIR Board of Directors in January 1998. In 1990, he founded Tanabe
Research Labatories, USA, Inc., a wholly owned subsidiary of Tanabe
Seiyaku of Osaka, Japan, and served as President and Chief Executive
Officer for five years. From 1987 until 1990, Dr. Yakatan served as
Executive Vice President for Research and Development for Immunetech
Pharmaceuticals. In 1980, Dr. Yakatan joined Warner-Lambert Company,
Pharmceutical Research Division, as Director of Pharmacokinetics and
Drug Metabolism. Three years later, he was appointed Vice President of
Product Development. Dr. Yakatan has published more than sixty papers in
scientific and professionals journals in the areas of pharmacokinetics,
biopharmaceuticals, analysis of drugs in biological fluids and drug
stability. He is a fellow of the American Association of Pharmaceutical
Scientists (AAPS) and the American College of Clinical Pharmacology
(ACCP) and is a registered pharmacist in Pennsylvania and Florida. Profile
Dr. Yakatan: AVANIR Pharmaceuticals is a specialty pharmaceutical
company with an extra part to it, in that we are also an
